These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24788596)

  • 1. Metformin inhibits proliferation and enhances chemosensitivity of intrahepatic cholangiocarcinoma cell lines.
    Ling S; Feng T; Ke Q; Fan N; Li L; Li Z; Dong C; Wang C; Xu F; Li Y; Wang L
    Oncol Rep; 2014 Jun; 31(6):2611-8. PubMed ID: 24788596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
    Ling S; Xie H; Yang F; Shan Q; Dai H; Zhuo J; Wei X; Song P; Zhou L; Xu X; Zheng S
    J Hematol Oncol; 2017 Feb; 10(1):59. PubMed ID: 28241849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notch1 is overexpressed in human intrahepatic cholangiocarcinoma and is associated with its proliferation, invasiveness and sensitivity to 5-fluorouracil in vitro.
    Wu WR; Zhang R; Shi XD; Zhu MS; Xu LB; Zeng H; Liu C
    Oncol Rep; 2014 Jun; 31(6):2515-24. PubMed ID: 24700253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin enhances cisplatin induced inhibition of cholangiocarcinoma cells via AMPK-mTOR pathway.
    Wandee J; Prawan A; Senggunprai L; Kongpetch S; Tusskorn O; Kukongviriyapan V
    Life Sci; 2018 Aug; 207():172-183. PubMed ID: 29847773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
    Yang SH; Lin HY; Chang VH; Chen CC; Liu YR; Wang J; Zhang K; Jiang X; Yen Y
    Oncotarget; 2015 Sep; 6(27):23857-73. PubMed ID: 26160843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Metformin Use for Cholangiocarcinoma.
    Kaewpitoon SJ; Loyd RA; Rujirakul R; Panpimanmas S; Matrakool L; Tongtawee T; Kootanavanichpong N; Kompor P; Chavengkun W; Kujapun J; Norkaew J; Ponphimai S; Padchasuwan N; Pholsripradit P; Eksanti T; Phatisena T; Kaewpitoon N
    Asian Pac J Cancer Prev; 2015; 16(18):8079-83. PubMed ID: 26745042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
    Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice.
    Zhang S; Song X; Cao D; Xu Z; Fan B; Che L; Hu J; Chen B; Dong M; Pilo MG; Cigliano A; Evert K; Ribback S; Dombrowski F; Pascale RM; Cossu A; Vidili G; Porcu A; Simile MM; Pes GM; Giannelli G; Gordan J; Wei L; Evert M; Cong W; Calvisi DF; Chen X
    J Hepatol; 2017 Dec; 67(6):1194-1203. PubMed ID: 28733220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAZ regulates cell proliferation and sensitivity to vitamin D3 in intrahepatic cholangiocarcinoma.
    Xiao H; Tong R; Yang B; Lv Z; Du C; Peng C; Ding C; Cheng S; Zhou L; Xie H; Wu J; Zheng S
    Cancer Lett; 2016 Oct; 381(2):370-9. PubMed ID: 27554639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: an in vivo and in vitro study.
    Li S; Han Z; Ma Y; Song R; Pei T; Zheng T; Wang J; Xu D; Fang X; Jiang H; Liu L
    Oncol Rep; 2014 Jan; 31(1):145-52. PubMed ID: 24247752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma.
    Hou YJ; Dong LW; Tan YX; Yang GZ; Pan YF; Li Z; Tang L; Wang M; Wang Q; Wang HY
    Lab Invest; 2011 Aug; 91(8):1146-57. PubMed ID: 21647092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits both motility through down-regulation of p-STAT3 (S727) by disrupting the mTORC2 assembly and peritoneal dissemination in sarcomatoid cholangiocarcinoma.
    Hong SM; Park CW; Cha HJ; Kwon JH; Yun YS; Lee NG; Kim DG; Nam HG; Choi KY
    Clin Exp Metastasis; 2013 Feb; 30(2):177-87. PubMed ID: 22875246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPK.
    Feng T; Li L; Ling S; Fan N; Fang M; Zhang H; Fang X; Lan W; Hou Z; Meng Q; Jin D; Xu F; Li Y
    Biomed Pharmacother; 2015 Feb; 69():260-6. PubMed ID: 25661368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dual effects of delta(9)-tetrahydrocannabinol on cholangiocarcinoma cells: anti-invasion activity at low concentration and apoptosis induction at high concentration.
    Leelawat S; Leelawat K; Narong S; Matangkasombut O
    Cancer Invest; 2010 May; 28(4):357-63. PubMed ID: 19916793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
    Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
    Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma.
    Gan L; Shen H; Li X; Han Z; Jing Y; Yang X; Wu M; Xia Y
    Oncol Rep; 2021 Jan; 45(1):107-118. PubMed ID: 33155663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RA190, a Proteasome Subunit ADRM1 Inhibitor, Suppresses Intrahepatic Cholangiocarcinoma by Inducing NF-KB-Mediated Cell Apoptosis.
    Yu GY; Wang X; Zheng SS; Gao XM; Jia QA; Zhu WW; Lu L; Jia HL; Chen JH; Dong QZ; Lu M; Qin LX
    Cell Physiol Biochem; 2018; 47(3):1152-1166. PubMed ID: 29913454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.
    Li B; Takeda T; Tsuiji K; Kondo A; Kitamura M; Wong TF; Yaegashi N
    Gynecol Endocrinol; 2013 Jan; 29(1):87-90. PubMed ID: 22835064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triptolide inhibits intrahepatic cholangiocarcinoma growth by suppressing glycolysis via the AKT/mTOR pathway.
    Li L; Wang C; Qiu Z; Deng D; Chen X; Wang Q; Meng Y; Zhang B; Zheng G; Hu J
    Phytomedicine; 2023 Jan; 109():154575. PubMed ID: 36610163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
    Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
    Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.